Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens

BACKGROUND: With the introduction of integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART), persons living with HIV have a potent new treatment option. Recently, providers at our large treatment clinic noted weight gain in several patients switched from efavirenz/tenofovir d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Acquir Immune Defic Syndr
Autori principali: Norwood, Jamison, Turner, Megan, Bofill, Carmen, Rebeiro, Peter, Shepherd, Bryan, Bebawy, Sally, Hulgan, Todd, Raffanti, Stephen, Haas, David W., Sterling, Timothy R., Koethe, John R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680113/
https://ncbi.nlm.nih.gov/pubmed/28825943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001525
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi